Adrenomedullin in the treatment of pulmonary hypertension.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Peptides

• Publication date

  2004-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.PEPTIDES.2004.07.007PMID 15501535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Adrenomedullin Inhalation on Hemodynamics and Exercise Capacity in Patients With Idiopathic Pulmonary Arterial Hypertension

  2004cited by this paper
• Endothelial Dysfunction in Pulmonary Hypertension

  2004cited by this paper
• Hybrid Cell–Gene Therapy for Pulmonary Hypertension Based on Phagocytosing Action of Endothelial Progenitor Cells

  2003cited by this paper
• Repeated inhalation of adrenomedullin ameliorates pulmonary hypertension and survival in monocrotaline rats.

  2003cited by this paper
• Adrenomedullin Induces Endothelium-Dependent Vasorelaxation via the Phosphatidylinositol 3-Kinase/Akt-Dependent Pathway in Rat Aorta

  2001cited by this paper
• Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment

  2001cited by this paper
• Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study.

  2001cited by this paper
• Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+AC133+ Endothelial Precursor Cells

  2001cited by this paper
• Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia

  2001cited by this paper
• Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure.

  2000cited by this paper
• Adrenomedullin: potential in physiology and pathophysiology.

  2000cited by this paper
• Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.

  2000cited by this paper
• Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".

  2000cited by this paper
• Cardiac adrenomedullin gene expression and peptide accumulation after acute myocardial infarction in rats.

  2000cited by this paper
• Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension

  2000cited by this paper
• Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers.

  2000cited by this paper
• Endothelial dysfunction associated with left ventricular diastolic dysfunction in patients with coronary heart disease.

  2000cited by this paper
• Comparison of intravenous adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure.

  2000cited by this paper
• Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization.

  2000cited by this paper
• Increased plasma levels of adrenomedullin in patients with pulmonary hypertension.

  1999cited by this paper
• Antiinflammatory activity of adrenomedullin in the acetic acid peritonitis in rats.

  1999cited by this paper
• Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization

  1999cited by this paper
• Cardiovascular and renal effects of adrenomedullin in rats with heart failure.

  1999cited by this paper
• Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

  1999cited by this paper
• Bioactivity and interactions of adrenomedullin and brain natriuretic peptide in patients with heart failure.

  1999cited by this paper
• Cardiovascular and renal effects of adrenomedullin in rats with heart failure.

  1999cited by this paper
• Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes.

  1998cited by this paper
• Plasma levels of adrenomedullin in patients with acute myocardial infarction.

  1998cited by this paper
• Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide.

  1998cited by this paper
• RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor

  1998cited by this paper
• Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

  1998cited by this paper
• Cardiac Secretion of Adrenomedullin by Percutaneous Transluminal Coronary Angioplasty

  1997cited by this paper
• Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure.

  1997cited by this paper
• Plasma levels of adrenomedullin in primary and secondary pulmonary hypertension in patients <20 years of age.

  1997cited by this paper
• Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

  1997cited by this paper
• Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure.

  1997cited by this paper
• Renal responses to intra-arterial administration of adrenomedullin in dogs.

  1996cited by this paper
• Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells

  1996cited by this paper
• A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.

  1996cited by this paper
• Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats.

  1996cited by this paper
• Atrial natriuretic peptide increases adrenomedullin in the circulation of healthy humans.

  1996cited by this paper
• An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat.

  1995cited by this paper
• Increased plasma levels of adrenomedullin in patients with heart failure.

  1995cited by this paper
• Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells.

  1995cited by this paper
• Pulmonary vasodilation to adrenomedullin: a novel peptide in humans.

  1995cited by this paper
• ACTH‐Suppressive and Vasodilator Actions of Adrenomedullin in Conscious Sheep

  1995cited by this paper
• Cardiovascular and neurohormonal effects of intravenous adrenomedullin in conscious rabbits.

  1995cited by this paper
• Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla.

  1995cited by this paper
• Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma

  1994cited by this paper
• Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.

  1994cited by this paper
• Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells.

  1994cited by this paper
• Adrenomedullin dilates the pulmonary vascular bed in vivo.

  1994cited by this paper
• Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells.

  1994cited by this paper
• Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma

  1994cited by this paper
• Aerosolised prostacyclin in adult respiratory distress syndrome.

  1993cited by this paper
• Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats.

  1993cited by this paper
• Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.

  1993cited by this paper
• An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.

  1992cited by this paper
• Single‐Lung Transplantation for Pulmonary Hypertension: Three‐Month Hemodynamic Follow‐up

  1991cited by this paper
• Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol): Results of a Randomized Trial

  1990cited by this paper
• Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.

  1990cited by this paper
• Primary pulmonary hypertension

  1988cited by this paper
• Primary pulmonary hypertension.

  1988cited by this paper
• Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension.

  1988cited by this paper
• Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function.

  1987cited by this paper
• PRIMARY PULMONARY HYPERTENSION: A NATIONAL PROSPECTIVE STUDY

  1987cited by this paper
• Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin).

  1984cited by this paper
• Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease.

  1982cited by this paper
• LIVER IN REGULATION OF FIBRINOLYTIC ACTIVITY.

  1964cited by this paper
• Chronic Hypoxia-induced Pulmonary Hypertension in the Mouse Related Peptide to the Lung Attenuates − in Vivo Gene Transfer of Prepro-calcitonin Gene in Vivo Gene Transfer of Prepro-calcitonin Gene–related Peptide to the Lung Attenuates Chronic Hypoxia-induced Pulmonary Hypertension in the Mouse

  year unknowncited by this paper

• Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update

  2024cites this paper
• Rational design of highly stabilized and selective adrenomedullin analogs

  2023cites this paper
• Stable adrenomedullin analog mitigates placental ischemia-induced hypertension and fetal growth restriction in rats

  2023cites this paper
• Sustained Activation of CLR/RAMP Receptors by Gel-Forming Agonists

  2022cites this paper
• An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers

  2022influential citation
• Novel and emerging therapies in pulmonary arterial hypertension

  2022cites this paper
• The Cardiopulmonary Effects of the Calcitonin Gene-related Peptide Family.

  2020cites this paper
• Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension

  2020cites this paper
• Adrenomedullin - Current Perspective on a Peptide Hormone with Significant Therapeutic Potential.

  2020cites this paper
• Fremanezumab for the preventive treatment of migraine in adults

  2019cites this paper
• Effect of intermedin/adrenomedullin2 on the pulmonary vascular bed in hypoxia‐induced pulmonary hypertensive rats

  2018cites this paper
• Midregional proadrenomedullin predicts reduced blood pressure and glucose elevation over time despite enhanced progression of obesity markers

  2018cites this paper
• Adrenomedullin – new perspectives of a potent peptide hormone

  2017cites this paper
• Lungs at high-altitude: genomic insights into hypoxic responses.

  2015cites this paper
• Vascular endothelial dysfunction and pharmacological treatment.

  2015cites this paper
• Treatment of Chronic Right Heart Failure

  2015cites this paper
• Efeitos da adrenomodulina no tratamento da hipertensão pulmonar induzida por microesferas em ovinos

  2015cites this paper
• Endothelial progenitor cells and pulmonary arterial hypertension.

  2014cites this paper
• Novel and emerging therapies for pulmonary hypertension.

  2014cites this paper
• Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension

  2013cites this paper
• Changes of Gene Expression after Bone Marrow Cell Transfusion in Rats with Monocrotaline-Induced Pulmonary Hypertension

  2012cites this paper
• Role of Endothelium in the Development of Pulmonary Hypertension

  2011influential citation
• Inhalational therapy for pulmonary arterial hypertension: current status and future prospects.

  2010cites this paper
• Idiopathic Pulmonary Hypertension: New Challenges

  2010cites this paper
• Emerging therapies for the treatment of pulmonary hypertension.

  2010cites this paper
• CT, CGRP, Amylin, and Adrenomedullins

  2009cites this paper
• The Plasma Concentration Levels of Adrenomedullin in Egyptian Patients Complaining of Mitral Stenosis, With and Without Pulmonary Hypertension

  2009cites this paper
• Treatment of Pulmonary Arterial Hypertension: A Look to the Future

  2008cites this paper
• Treatment of pulmonary arterial hypertension due to scleroderma: challenges for the future.

  2008cites this paper
• Combination therapy and new types of agents for pulmonary arterial hypertension.

  2007cites this paper
• Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction.

  2007cites this paper
• Current drug targets and future therapy of pulmonary arterial hypertension.

  2007cites this paper
• Adrenomedullin facilitates reinnervation of phenol-injured perivascular nerves in the rat mesenteric resistance artery.

  2007cites this paper
• Adrenomedullin in the rostral ventrolateral medulla inhibits baroreflex control of heart rate: a role for protein kinase A

  2006cites this paper
• Pulmonary arterial hypertension.

  2006cites this paper
• Mediators and modulators of pulmonary arterial hypertension.

  2006cites this paper
• New therapeutic agents for pulmonary vascular disease.

  2005cites this paper
• Adrenomedullin: molecular mechanisms and its role in cardiac disease

  2005cites this paper
• Adrenomedullin Causes Coronary Vasodilation in Humans: Effects of Inhibition of Nitric Oxide Synthesis

  2005cites this paper
• Adrenomedullin treatment abolishes ileal mucosal hypoperfusion induced by Staphylococcus aureus &agr;-toxin—An intravital microscopic study on an isolated rat ileum

  2005cites this paper
• Introductory notes. Old and new paradigms in the field of the calcitonin family of peptides.

  2004cites this paper